TTY Biopharm Co Ltd (4105) — Strategic Asset Allocation Index
TTY Biopharm Co Ltd (4105) has a Strategic Asset Allocation Index of 40.0% as of June 2023. Strategic assets (PP&E of NT$2.38 Billion plus long-term investments of NT$-) total NT$2.38 Billion, measured against net assets of NT$5.95 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
TTY Biopharm Co Ltd Strategic Asset Allocation Index (2017–2022)
This chart shows how TTY Biopharm Co Ltd's Strategic Asset Allocation Index has evolved across 6 annual periods from 2017 to 2022. As of June 2023, the index stands at 40.0%, representing strategic assets of NT$2.38 Billion against net assets of NT$5.95 Billion TWD. Explore 4105 operating cash flow to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for TTY Biopharm Co Ltd (2017–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for TTY Biopharm Co Ltd from 2017 to 2022, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see TTY Biopharm Co Ltd stock valuation.
| Year | SAAI | Strategic Assets (TWD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 39.0% | NT$2.43 Billion | NT$2.43 Billion | NT$- | NT$6.23 Billion | ▼ -4.6 pp |
| 2021 | 43.7% | NT$2.52 Billion | NT$2.52 Billion | NT$- | NT$5.77 Billion | ▲ +1.2 pp |
| 2020 | 42.5% | NT$2.58 Billion | NT$2.58 Billion | NT$- | NT$6.08 Billion | ▲ +3.7 pp |
| 2019 | 38.8% | NT$2.39 Billion | NT$2.39 Billion | NT$- | NT$6.17 Billion | ▲ +0.1 pp |
| 2018 | 38.7% | NT$2.47 Billion | NT$2.47 Billion | NT$- | NT$6.39 Billion | ▼ -3.0 pp |
| 2017 | 41.7% | NT$2.55 Billion | NT$2.55 Billion | NT$- | NT$6.11 Billion | — |